Effect of puerarin on matrix metalloproteinase-2 in human fetal scleral fibroblasts treated with low frequency

Abstract

Insights

Extremely low frequency electromagnetic fields (ELF-EMF) exposure increased matrix metalloproteinase-2 (MMP-2) in scleral fibroblasts. Puerarin mitigated this effect, suggesting potential protection for scleral tissue against ELF-EMF damage.

Area of Science:

  • Ophthalmology
  • Cell Biology
  • Biophysics

Background:

  • Human fetal scleral fibroblasts (HFSFs) are crucial for maintaining scleral tissue integrity.
  • Matrix metalloproteinase-2 (MMP-2) plays a role in extracellular matrix remodeling.
  • Exposure to extremely low frequency electromagnetic fields (ELF-EMF) may impact cellular functions.

Purpose of the Study:

  • To investigate the impact of ELF-EMF on MMP-2 gene and protein expression in HFSFs.
  • To evaluate the protective effect of puerarin against ELF-EMF-induced changes in MMP-2 expression.

Main Methods:

  • HFSFs were exposed to 0.2 mT ELF-EMF for 24 hours.
  • Cells were treated with varying concentrations of puerarin (0, 0.1, 1, and 10 microM).
  • MMP-2 mRNA and protein levels were quantified using real-time PCR and Western blot analysis.

Main Results:

  • ELF-EMF exposure significantly increased MMP-2 mRNA and protein expression in HFSFs.
  • Puerarin treatment dose-dependently reversed these increases.
  • Significant protective effects were observed at concentrations of 0.1 microM and higher.

Conclusions:

  • ELF-EMF exposure elevates MMP-2 expression in HFSFs.
  • Puerarin demonstrates a protective effect by reversing ELF-EMF-induced MMP-2 upregulation.
  • Puerarin may offer a therapeutic strategy to protect scleral tissue from ELF-EMF-related damage.

Related Concept Videos